Sensus Healthcare, Inc.(SRTS)Earnings, Financials & Key Ratios

SRTS•NASDAQ

$3.04

Price updated Jun 27, 2026

SectorHealthcare IndustryMedical Devices Sub-IndustryImaging, radiation, and oncology devices

AboutSensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.Show more

Revenue$27M-34.3%
EBITDA-$10M-216.4%
Net Income-$8M-216.1%
EPS (Diluted)-0.47-214.6%
Gross Margin43.18%-26.1%
EBITDA Margin-36.1%-277.1%
Operating Margin-37.5%-293.8%
Net Margin-28.09%-276.7%
ROE-14.85%-217.0%

SRTS Price & Volume

Sensus Healthcare, Inc. (SRTS) stock price & volume — 10-year historical chart

Loading chart...

Sensus Healthcare Faces Severe Revenue Contraction Headwinds

Investment Thesis • Updated 2026Q1

VerdictNegative

Growth:Contracting

Profitability:Negative

Financial Position:Healthy

Cash Flow:Burning

Primary Risk:Reimbursement and sales volatility

"Sensus Healthcare is currently navigating a challenging period of operational deleveraging, characterized by a sharp decline in top-line revenue from $12.6M in 2023Q4 to $3.4M in 2026Q1. While the company maintains a fortress balance sheet with a 7.27 current ratio and minimal debt, the erosion of gross margins to 29.2% suggests significant pricing pressure and a struggle to maintain its installed base. Investors should monitor whether the company can stabilize its capital equipment sales cycle before its $18.3M cash position is further depleted by persistent quarterly net losses."

Verdict Logic

the company's transition from an operating profit of $5.6M in 2023Q4 to an operating loss of $4.4M in 2026Q1 indicates a fundamental deterioration in business model sustainability.

SRTS Growth Metrics

Sensus Healthcare, Inc. (SRTS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years10.34%

5 Years23.47%

3 Years-14.86%

TTM-42.94%

Profit CAGR

10 Years-

5 Years-

3 Years-

TTM-531.59%

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM-540.47%

Return on Capital

10 Years-2.79%

5 Years10.17%

3 Years-1.73%

Last Year-19.71%

Peers Comparison

Key metrics vs top competitors for Sensus Healthcare, Inc. (SRTS)

Full Screener →

Company	Price	Market Cap	P/E Ratio	Rev Growth (1Y)	Net Margin	ROE	Div Yield
SRTSSensus Healthcare, Inc.Current	$3.04	$50.04M	-6.47	-34.26%	-28.09%	-14.85%	—
XTLBXTL Biopharmaceuticals Ltd.	$2.36	$259.66K	-0.25	—	-227.72%	-25.53%	—
STXSStereotaxis, Inc.	$1.68	$164.2M	-6.72	20.28%	-69.5%	-153.21%	—
ARAYAccuray Incorporated	$0.29	$34.77M	-18.86	2.68%	-10.76%	-77.48%	—
ISRGIntuitive Surgical, Inc.	$404.27	$143.58B	51.37	20.51%	28.15%	16.89%	—
GKOSGlaukos Corporation	$144.42	$8.45B	-44.03	32.33%	-34.34%	-26.46%	—